{Reference Type}: Letter
{Title}: Tenascin C is a valuable marker for melanoma progression independent of mutational status and MAPK inhibitor therapy.
{Author}: Fromme JE;Dummer R;Mauch C;Zigrino P;
{Journal}: Exp Dermatol
{Volume}: 32
{Issue}: 5
{Year}: 05 2023 27
{Factor}: 4.511
{DOI}: 10.1111/exd.14717